Literature DB >> 21665132

Epidemiology of large-vessel vasculidities.

Bethan L Richards1, Lyn March, Sherine E Gabriel.   

Abstract

The systemic vasculitides are multisystem disorders characterised by the inflammation of blood vessels and tissue necrosis. Classified by the size of the vessels affected, the large vessel vasculitides include giant cell arteritis (GCA) and Takayasu's arteritis (TA). These are anatomically, epidemiologically and clinically distinct conditions. They are often associated with considerable morbidity and mortality. The classification of vasculitis has been an area of controversy for many years and current classification criteria remain suboptimal. Although intensive efforts are under way to improve them, a further understanding of the aetiology and pathogenesis of these diseases is required to develop more sensitive and specific diagnostic tests. These efforts, however, have been hampered by the low prevalence of these diseases. The establishment of national and international registries is encouraged to enhance valuable data collection. These are anatomically, epidemiologically and clinically distinct conditions. This article summarises the current classification systems for systemic vasculitis and their limitations. We also review the presently known epidemiology, risk factors and morbidity and mortality associated with GCA and TA. 2010. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21665132     DOI: 10.1016/j.berh.2010.10.008

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  12 in total

1.  Surgical Repair of Abdominal Aortic and Renal Artery Aneurysms in Takayasu's Arteritis.

Authors:  Paul J Wetstein; Margaret E Clark; Danielle E Cafasso; Scott R Golarz; Farhan S Ayubi; Dwight C Kellicut
Journal:  Hawaii J Med Public Health       Date:  2016-01

Review 2.  Aging in Primary Systemic Vasculitis: Implications for Diagnosis, Clinical Manifestations, and Management.

Authors:  Alvise Berti; Roberto Caporali; Carlomaurizio Montecucco; Giuseppe Paolazzi; Sara Monti
Journal:  Drugs Aging       Date:  2019-01       Impact factor: 3.923

3.  Giant cell arteritis in patients of Indian Subcontinental descent in the UK.

Authors:  N Tan; J Acheson; N Ali
Journal:  Eye (Lond)       Date:  2018-10-12       Impact factor: 3.775

Review 4.  The use and abuse of diagnostic/classification criteria.

Authors:  Rayford R June; Rohit Aggarwal
Journal:  Best Pract Res Clin Rheumatol       Date:  2015-05-23       Impact factor: 4.098

Review 5.  Takayasu arteritis - epidemiology, pathogenesis, diagnosis and treatment.

Authors:  Dominika Podgorska; Rafal Podgorski; David Aebisher; Piotr Dabrowski
Journal:  J Appl Biomed       Date:  2019-01-09       Impact factor: 1.797

Review 6.  Large-vessel vasculitis.

Authors:  Dan Pugh; Maira Karabayas; Neil Basu; Maria C Cid; Ruchika Goel; Carl S Goodyear; Peter C Grayson; Stephen P McAdoo; Justin C Mason; Catherine Owen; Cornelia M Weyand; Taryn Youngstein; Neeraj Dhaun
Journal:  Nat Rev Dis Primers       Date:  2022-01-06       Impact factor: 65.038

Review 7.  Immune mechanisms in medium and large-vessel vasculitis.

Authors:  Cornelia M Weyand; Jörg J Goronzy
Journal:  Nat Rev Rheumatol       Date:  2013-11-05       Impact factor: 20.543

8.  Pathology of Takayasu arteritis: A brief review.

Authors:  Pradeep Vaideeswar; Jaya R Deshpande
Journal:  Ann Pediatr Cardiol       Date:  2013-01

Review 9.  The Role of Perivascular Adipose Tissue in Non-atherosclerotic Vascular Disease.

Authors:  Tetsuo Horimatsu; Ha Won Kim; Neal L Weintraub
Journal:  Front Physiol       Date:  2017-11-28       Impact factor: 4.566

10.  Giant cell arteritis: a multicenter observational study in Brazil.

Authors:  Alexandre Wagner Silva de Souza; Karine Yoshiye Kajiyama Okamoto; Fabiano Abrantes; Bruno Schau; Ana Beatriz Santos Bacchiega; Samuel Katsuyuki Shinjo
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.